BG103931A - Метод за получаване на лекарства, които включват нмg-соа-редуктазни инхибитори - Google Patents

Метод за получаване на лекарства, които включват нмg-соа-редуктазни инхибитори

Info

Publication number
BG103931A
BG103931A BG103931A BG10393199A BG103931A BG 103931 A BG103931 A BG 103931A BG 103931 A BG103931 A BG 103931A BG 10393199 A BG10393199 A BG 10393199A BG 103931 A BG103931 A BG 103931A
Authority
BG
Bulgaria
Prior art keywords
coa
preparation
reductase inhibitors
medicaments including
including hmg
Prior art date
Application number
BG103931A
Other languages
English (en)
Inventor
Fritz Schuckler
Karl Geisen
Norbert Poellinger
Samir Samaan
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG103931A publication Critical patent/BG103931A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретението се отнася до метод за получаване налекарства, които включват HMG-CoA-редуктазни инхибитори под формата на техни соли. Съответните изходни активни вещества се превръщат с бази, които сав разтвор и съдържат алкални или алкалоземни йони, в активно съединение. Полученият разтвор, съдържащ активно съединение, се формулира в лекарствени препарати.
BG103931A 1997-06-16 1999-11-30 Метод за получаване на лекарства, които включват нмg-соа-редуктазни инхибитори BG103931A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19725391A DE19725391A1 (de) 1997-06-16 1997-06-16 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren
PCT/EP1998/003294 WO1998057917A1 (de) 1997-06-16 1998-06-03 VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ENTHALTEND HMG-CoA- REDUKTASEINHIBITOREN

Publications (1)

Publication Number Publication Date
BG103931A true BG103931A (bg) 2000-07-31

Family

ID=7832616

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103931A BG103931A (bg) 1997-06-16 1999-11-30 Метод за получаване на лекарства, които включват нмg-соа-редуктазни инхибитори

Country Status (23)

Country Link
US (2) US20020146454A1 (bg)
EP (1) EP0991616B1 (bg)
JP (1) JP2002504126A (bg)
KR (1) KR20010013792A (bg)
CN (1) CN1260774A (bg)
AR (1) AR012963A1 (bg)
AT (1) ATE240925T1 (bg)
AU (1) AU734787B2 (bg)
BG (1) BG103931A (bg)
BR (1) BR9810129A (bg)
CA (1) CA2294724A1 (bg)
DE (2) DE19725391A1 (bg)
ES (1) ES2198728T3 (bg)
HU (1) HUP0002720A3 (bg)
ID (1) ID23179A (bg)
IL (1) IL132987A0 (bg)
NO (1) NO996183D0 (bg)
NZ (1) NZ501760A (bg)
PL (1) PL337343A1 (bg)
SK (1) SK171199A3 (bg)
TR (1) TR199902871T2 (bg)
WO (1) WO1998057917A1 (bg)
ZA (1) ZA985179B (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44578E1 (en) 2000-04-10 2013-11-05 Teva Pharmaceutical Industries, Ltd. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
DK2382970T3 (da) * 2000-04-10 2013-03-25 Teva Pharma Stabile farmaceutiske sammensætninger, der indeholder 7-substitueret-3,5-dihydroxyheptansyrer eller 7-substitueret-3,5-dihydroxyheptensyrer
EP1810667A1 (en) * 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
DE69324504T2 (de) * 1993-01-19 1999-08-26 Warner Lambert Co Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren

Also Published As

Publication number Publication date
TR199902871T2 (xx) 2000-02-21
CN1260774A (zh) 2000-07-19
DE59808476D1 (de) 2003-06-26
NO996183L (no) 1999-12-14
ID23179A (id) 2000-03-23
AR012963A1 (es) 2000-11-22
EP0991616A1 (de) 2000-04-12
EP0991616B1 (de) 2003-05-21
PL337343A1 (en) 2000-08-14
US20030203964A1 (en) 2003-10-30
BR9810129A (pt) 2000-08-08
DE19725391A1 (de) 1998-12-17
CA2294724A1 (en) 1998-12-23
AU8335398A (en) 1999-01-04
US20020146454A1 (en) 2002-10-10
AU734787B2 (en) 2001-06-21
SK171199A3 (en) 2000-07-11
ES2198728T3 (es) 2004-02-01
NZ501760A (en) 2001-05-25
ATE240925T1 (de) 2003-06-15
KR20010013792A (ko) 2001-02-26
NO996183D0 (no) 1999-12-14
WO1998057917A1 (de) 1998-12-23
HUP0002720A3 (en) 2001-12-28
HUP0002720A2 (hu) 2000-12-28
IL132987A0 (en) 2001-03-19
JP2002504126A (ja) 2002-02-05
ZA985179B (en) 1999-01-08

Similar Documents

Publication Publication Date Title
HUT67398A (en) 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
ES8802045A1 (es) Procedimiento para la produccion de tiazoles
HUT50794A (en) Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients
BG102172A (bg) Фармацевтични препарати за получаване на аерозоли, свободни от пропелант
MY101791A (en) New benzimidazole derivatives
BG103482A (bg) Използване на воден лекарствен препарат за получаване на аерозоли, несъдържащи пропелант
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
CS960586A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
BG104256A (bg) Лекарствен препарат с контролирано освобождаване на активно съединение
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
HUT41213A (en) Pesticide compositions containing benzodioxole derivatives as active ingredients and process for preparing the active compounds
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
BG103931A (bg) Метод за получаване на лекарства, които включват нмg-соа-редуктазни инхибитори
HUT47127A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient
ES8608516A1 (es) Procedimiento para la preparacion de acidos 4-isoxazolil- tiazol-2-oxamicos y sus derivados
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents
AU7841387A (en) 4-substituted-2,6-diphenylpyridine derivatives, production of the same, and herbicide containing the same as an active ingredient
BG101983A (bg) Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване
GR3023044T3 (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors.
ES8801295A1 (es) Un procedimiento para preparar derivados de fosfina